SETD2 and cancer: However, CREB1 phosphorylation contributes to cisplatin sensitivity in lung cancer cells via regulation of the ERK pathway, especially in cancer cells with mutated SET domain containing 2 (SETD2), a histone H3 lysine 36 (H3K36) trimethyltransferase [99].